P1038 TL-895, A first-in-class, covalent bruton tyrosine kinase inhibitor (BTKI) for the treatment of myelofibrosis (MF) patients (PTS) with severe thrombocytopenia (platelets (PLTS)<50 K/UL)
| dc.contributor.author | Loschi, Michael | |
| dc.contributor.author | Rejtő, László | |
| dc.contributor.author | Chuah, Hun | |
| dc.contributor.author | Caramella, Marianna | |
| dc.contributor.author | Hernández Rivas, Jesus | |
| dc.contributor.author | Sportoletti, Paolo | |
| dc.contributor.author | Dubruille, Viviane | |
| dc.contributor.author | Bellesso, Marcelo | |
| dc.contributor.author | Gröpper, Stefanie | |
| dc.contributor.author | Crodel, Carl | |
| dc.contributor.author | Qamoos, Hope | |
| dc.contributor.author | Socotch, Ashley | |
| dc.contributor.author | Huang, Zhuying | |
| dc.contributor.author | Wall, Sarah | |
| dc.contributor.author | McGreivy, Jesse S. | |
| dc.contributor.author | Rothbaum, Wayne | |
| dc.contributor.author | Verstovsek, Srdan | |
| dc.contributor.author | Palandri, Francesca | |
| dc.date.accessioned | 2023-09-11T09:43:24Z | |
| dc.date.available | 2023-09-11T09:43:24Z | |
| dc.date.issued | 2023 | |
| dc.date.oa | 2024-06-14 | |
| dc.date.pasync | 2025-01-24T00:07:14Z | |
| dc.date.updated | 2023-09-11T09:43:23Z | |
| dc.description.corrector | LB | |
| dc.identifier.citation | HemaSphere. -7 : Suppl_3 (2023), p. 1983-1985. -(cikkazonosító)e09624cd. -Hemasphere. - 2572-9241 | |
| dc.identifier.doi | http://dx.doi.org/10.1097/01.HS9.0000971048.09624.cd | |
| dc.identifier.issn | 2572-9241 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM114551 | |
| dc.identifier.uri | https://hdl.handle.net/2437/358843 | |
| dc.identifier.url | https://journals.lww.com/10.1097/01.HS9.0000971048.09624.cd | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | P1038 TL-895, A first-in-class, covalent bruton tyrosine kinase inhibitor (BTKI) for the treatment of myelofibrosis (MF) patients (PTS) with severe thrombocytopenia (platelets (PLTS)<50 K/UL) | |
| dc.type | folyóiratcikk | |
| dc.type | idézhető absztrakt |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_9_p1038 TL-895 a first-in-class.pdf
- Méret:
- 1.19 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- Kiadói változat